Veradermics (MANE) PT Raised to $138 at Jefferies
Jefferies analyst Roger Song raised the price target on Veradermics (NYSE: MANE) to $138.00 (from $111.00) while maintaining a Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
